Suppr超能文献

P2Y 受体对 THP-1 人单核细胞细胞内 ADP 诱导的 Ca 信号转导的调节作用。

P2Y receptor modulation of ADP-evoked intracellular Ca signalling in THP-1 human monocytic cells.

机构信息

Biomedical Research Centre, School of Biological Sciences, University of East Anglia, Norwich, UK.

出版信息

Br J Pharmacol. 2018 Jun;175(12):2483-2491. doi: 10.1111/bph.14218. Epub 2018 Apr 29.

Abstract

BACKGROUND AND PURPOSE

The G -coupled, ADP-activated P2Y receptor is well characterized as playing a key role in platelet activation via crosstalk with the P2Y receptor in ADP-evoked intracellular Ca responses. However, there is limited knowledge on the role of P2Y receptors in ADP-evoked Ca responses in other blood cells. Here, we investigated the role of P2Y receptor activation in the modulation of ADP-evoked Ca responses in human THP-1 monocytic cells.

EXPERIMENTAL APPROACH

A combination of intracellular Ca measurements, RT-PCR, immunocytochemistry, leukocyte isolation and siRNA-mediated gene knockdown were used to identify the role of P2Y receptor activation.

KEY RESULTS

ADP-evoked intracellular Ca responses (EC 2.7 μM) in THP-1 cells were abolished by inhibition of PLC (U73122) or sarco/endoplasmic reticulum Ca -ATPase (thapsigargin). Loss of ADP-evoked Ca responses following treatment with MRS2578 (IC 200 nM) revealed a major role for P2Y receptors in mediating ADP-evoked Ca responses. ADP-evoked responses were attenuated either with pertussis toxin treatment, or P2Y receptor inhibition with two chemically distinct antagonists (ticagrelor, IC 5.3 μM; PSB-0739, IC 5.6 μM). ADP-evoked responses were suppressed following siRNA-mediated P2Y gene knockdown. The inhibitory effects of P2Y antagonists were fully reversed following adenylate cyclase inhibition (SQ22536). P2Y receptor expression was confirmed in freshly isolated human CD14 monocytes.

CONCLUSIONS AND IMPLICATIONS

Taken together, these data suggest that P2Y receptor activation positively regulates P2Y receptor-mediated intracellular Ca signalling through suppression of adenylate cyclase activity in human monocytic cells.

摘要

背景与目的

G 蛋白偶联、ADP 激活的 P2Y 受体通过与 ADP 诱导的细胞内 Ca 反应中的 P2Y 受体的串扰,很好地被描述为在血小板激活中发挥关键作用。然而,对于 P2Y 受体在 ADP 诱导的其他血细胞内 Ca 反应中的作用知之甚少。在此,我们研究了 P2Y 受体激活在调节人 THP-1 单核细胞中 ADP 诱导的 Ca 反应中的作用。

实验方法

采用细胞内 Ca 测量、RT-PCR、免疫细胞化学、白细胞分离和 siRNA 介导的基因敲低相结合的方法来确定 P2Y 受体激活的作用。

主要结果

在 THP-1 细胞中,ADP 诱导的细胞内 Ca 反应(EC 2.7 μM)被 PLC 抑制剂(U73122)或肌浆/内质网 Ca -ATP 酶(thapsigargin)抑制所消除。用 MRS2578(IC 200 nM)处理后,ADP 诱导的 Ca 反应的丧失表明 P2Y 受体在介导 ADP 诱导的 Ca 反应中起主要作用。ADP 诱导的反应在百日咳毒素处理或用两种化学上不同的拮抗剂(ticagrelor,IC 5.3 μM;PSB-0739,IC 5.6 μM)抑制 P2Y 受体后减弱。ADP 诱导的反应在 P2Y 基因敲低后的 siRNA 处理后被抑制。P2Y 拮抗剂的抑制作用在用腺苷酸环化酶抑制剂(SQ22536)处理后完全逆转。在新鲜分离的人 CD14 单核细胞中证实了 P2Y 受体的表达。

结论与意义

综上所述,这些数据表明,在人类单核细胞中,P2Y 受体激活通过抑制腺苷酸环化酶活性,正向调节 P2Y 受体介导的细胞内 Ca 信号转导。

相似文献

1
P2Y receptor modulation of ADP-evoked intracellular Ca signalling in THP-1 human monocytic cells.
Br J Pharmacol. 2018 Jun;175(12):2483-2491. doi: 10.1111/bph.14218. Epub 2018 Apr 29.
2
Competitive mode and site of interaction of ticagrelor at the human platelet P2Y12 -receptor.
J Thromb Haemost. 2014 Nov;12(11):1898-905. doi: 10.1111/jth.12719. Epub 2014 Sep 29.
3
P2Y and P2Y receptor activation elicits intracellular calcium responses in human adipose-derived mesenchymal stromal cells.
Purinergic Signal. 2018 Dec;14(4):371-384. doi: 10.1007/s11302-018-9618-3. Epub 2018 Aug 7.
6
Expression and function of purinergic P2Y12 receptors in rat trigeminal ganglion neurons.
Neurosci Res. 2015 Sep;98:17-27. doi: 10.1016/j.neures.2015.04.008. Epub 2015 May 15.
8
Nucleotide transmitters ATP and ADP mediate intercellular calcium wave communication via P2Y12/13 receptors among BV-2 microglia.
PLoS One. 2017 Aug 11;12(8):e0183114. doi: 10.1371/journal.pone.0183114. eCollection 2017.
9
Evidence for a PI3-kinase independent pathway in the regulation of Rap1b activation downstream of the P2Y12 receptor in platelets.
Platelets. 2022 Nov 17;33(8):1301-1306. doi: 10.1080/09537104.2022.2071855. Epub 2022 May 6.
10
Conventional protein kinase C isoforms differentially regulate ADP- and thrombin-evoked Ca²⁺ signalling in human platelets.
Cell Calcium. 2015 Dec;58(6):577-88. doi: 10.1016/j.ceca.2015.09.005. Epub 2015 Sep 28.

引用本文的文献

1
Sustainable Immunomodulatory via Macrophage P2Y12 Inhibition Mediated Bioactive Patche for Peritendinous Antiadhesion.
Adv Sci (Weinh). 2025 Jan;12(4):e2409128. doi: 10.1002/advs.202409128. Epub 2024 Dec 4.
2
Clopidogrel protects against gentamicin-induced nephrotoxicity through targeting oxidative stress, apoptosis, and coagulation pathways.
Naunyn Schmiedebergs Arch Pharmacol. 2025 Mar;398(3):2609-2625. doi: 10.1007/s00210-024-03380-5. Epub 2024 Sep 5.
4
Increased expression of the P2Y receptor is involved in the failure of autogenous arteriovenous fistula caused by stenosis.
Ren Fail. 2023;45(2):2278314. doi: 10.1080/0886022X.2023.2278314. Epub 2023 Nov 23.
5
Pharmacological interaction and immune response of purinergic receptors in therapeutic modulation.
Purinergic Signal. 2024 Aug;20(4):321-343. doi: 10.1007/s11302-023-09966-7. Epub 2023 Oct 16.
6
Purinergic receptor P2Y12 boosts autoimmune hepatitis through hexokinase 2-dependent glycolysis in T cells.
Int J Biol Sci. 2023 Jul 9;19(11):3576-3594. doi: 10.7150/ijbs.85133. eCollection 2023.
7
Clopidogrel Is Associated with Reduced Likelihood of Aneurysmal Subarachnoid Hemorrhage: a Multi-Center Matched Retrospective Analysis.
Transl Stroke Res. 2024 Oct;15(5):936-940. doi: 10.1007/s12975-023-01179-9. Epub 2023 Jul 20.
9
P2Y12 inhibitor clopidogrel inhibits renal fibrosis by blocking macrophage-to-myofibroblast transition.
Mol Ther. 2022 Sep 7;30(9):3017-3033. doi: 10.1016/j.ymthe.2022.06.019. Epub 2022 Jul 5.
10
Platelet-lymphocyte co-culture serves as an ex vivo platform of dynamic heterotypic cross-talk.
J Cell Commun Signal. 2022 Dec;16(4):661-675. doi: 10.1007/s12079-022-00676-0. Epub 2022 Apr 12.

本文引用的文献

2
THE CONCISE GUIDE TO PHARMACOLOGY 2017/18: G protein-coupled receptors.
Br J Pharmacol. 2017 Dec;174 Suppl 1(Suppl Suppl 1):S17-S129. doi: 10.1111/bph.13878.
3
THE CONCISE GUIDE TO PHARMACOLOGY 2017/18: Enzymes.
Br J Pharmacol. 2017 Dec;174 Suppl 1(Suppl Suppl 1):S272-S359. doi: 10.1111/bph.13877.
4
Extracellular ADP facilitates monocyte recruitment in bacterial infection via ERK signaling.
Cell Mol Immunol. 2018 Jan;15(1):58-73. doi: 10.1038/cmi.2016.56. Epub 2016 Nov 21.
5
Inverse agonism at the P2Y12 receptor and ENT1 transporter blockade contribute to platelet inhibition by ticagrelor.
Blood. 2016 Dec 8;128(23):2717-2728. doi: 10.1182/blood-2016-03-707844. Epub 2016 Sep 30.
6
Effects of P2Y12 receptor antagonists beyond platelet inhibition--comparison of ticagrelor with thienopyridines.
Br J Pharmacol. 2016 Apr;173(7):1163-78. doi: 10.1111/bph.13429. Epub 2016 Feb 24.
7
Experimental design and analysis and their reporting: new guidance for publication in BJP.
Br J Pharmacol. 2015 Jul;172(14):3461-71. doi: 10.1111/bph.12856.
8
Coupling of P2Y receptors to G proteins and other signaling pathways.
Wiley Interdiscip Rev Membr Transp Signal. 2012 Nov-Dec;1(6):789-803. doi: 10.1002/wmts.62.
9
P2Y₆ receptor inhibition perturbs CCL2-evoked signalling in human monocytic and peripheral blood mononuclear cells.
J Cell Sci. 2014 Nov 15;127(Pt 22):4964-73. doi: 10.1242/jcs.159012. Epub 2014 Sep 30.
10
Vessel wall, not platelet, P2Y12 potentiates early atherogenesis.
Cardiovasc Res. 2014 Jun 1;102(3):429-35. doi: 10.1093/cvr/cvu028. Epub 2014 Feb 7.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验